SecBot SecBot
DEFA14A ·Filed Apr 22, 2026

STOK

Stoke Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001193125-26-170393
Proxy solicitation materials
Actionable Insight • Neutral

Monitor next 10-Q for guidance revision

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$34.93
T+0 close · Apr 22, 2026 · via day close
Latest settled
−20.76%
T+60 · $27.68
Vs SPY
−25.77%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 23 $34.93entry
  2. T+1 · 7mo ago −2.58%α −3.36% · $34.03
  3. T+5 · 7mo ago −7.19%α −8.66% · $32.42
  4. T+20 · 6mo ago −13.27%α −17.90% · $30.30
  5. T+60 · 4mo ago −20.76%α −25.77% · $27.68
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Stoke Therapeutics' 2026 proxy statement details the election of three Class I directors, ratification of auditors, and advisory approval of executive compensation. This filing is routine governance material, routine for a biotech company.

Key Financial Metrics

Vote
director election
Meeting
2026-06-03
Seats Contested
3

Key Facts

  • Election of Class I directors: G. Clare Kahn, Ph.D., Adrian Krainer, Ph.D., and Julie Anne Smith
  • Ratification of Ernst & Young LLP as independent auditors for fiscal year 2026
  • Advisory vote on executive compensation

Financial Impact

Routine governance matters with no immediate financial impact

governanceexecutive compensation

Risk Factors

  • Potential for shareholder dissent on executive compensation
  • Board composition changes could affect strategic direction

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-170393
Document: 0001193125-26-170393-index-headers.html0001193125-26-170393
Document: 0001193125-26-170393-index.html0001193125-26-170393
Document: 0001193125-26-170393.txt0001193125-26-170393

US Market Status

Market Closed · Opens in 9h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 22, 2026